OraSure Technologies Inc OSUR:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/04/21 EST
10.75quote price arrow down-0.38 (-3.41%)
Volume
1,231,627
52 week range
5.23 - 19.75

...

Loading . . .

KEY STATS

  • Open11.08
  • Day High11.08
  • Day Low10.52
  • Prev Close10.75
  • 52 Week High19.75
  • 52 Week High Date08/05/20
  • 52 Week Low5.23
  • 52 Week Low Date03/13/20
  • Market Cap773.46M
  • Shares Out71.95M
  • 10 Day Average Volume1.67M
  • Dividend-
  • Dividend Yield-
  • Beta-0.19
  • 1 Year % Change73.67

RATIOS/PROFITABILITY

  • EPS (TTM)-0.24
  • P/E (TTM)-44.75
  • Fwd P/E (NTM)30.80
  • EBITDA (MRQ)4.603M
  • ROE (MRQ)-4.23%
  • Revenue (MRQ)171.72M
  • Gross Margin (MRQ)59.32%
  • Net Margin (MRQ)-8.69%
  • Debt To Equity (MRQ)0.35%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest OraSure Technologies Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection...
Michael Celano
Chairman
Stephen Tang Ph.D.
President
Roberto Cuca J.D.
Chief Financial Officer
Kathleen Weber
Executive Vice President
Lisa Nibauer
Executive Vice President
Michele Miller
Vice President - Finance
Address
150 WEBSTER ST
Bethlehem, PA
18015
United States